top of page

Improving your

Understanding of Theranostics

Theranostics is a cutting-edge approach in modern medicine that combines diagnostic and therapeutic capabilities into a single integrated platform. By utilising molecular imaging techniques, such as positron emission tomography (PET) or single-photon emission computed tomography (SPECT), theranostics enables clinicians to accurately diagnose diseases and assess their molecular characteristics. In addition to diagnosis, theranostics also involves the targeted delivery of therapeutic agents, such as radioactive isotopes or nanoparticles, to specific disease sites identified during imaging. This personalised treatment approach allows for precise and effective therapy tailored to individual patients, leading to improved outcomes and reduced side effects.

 

Theranostics represents a promising avenue for advancing precision medicine and transforming the way we diagnose and treat diseases.

More from our social media

Receptionist
OA logo

Working with Patients,
Policy & Practitioners

Contact us by email info@oncothera.com.au

  • LinkedIn

© Oncothera Pty Ltd. View our Privacy Policy & Disclaimer.

​

Site developed by Showoff Group.

Oncothera Advocacy is a Registered Charity with the Australian Charities and Not–for–profit Commission.

bottom of page